Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the Intestine

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2018 Feb 24

PMID 29473944

Citations 16

Authors

Harald S Hansen

Vasiliki Vana

Affiliations

Soon will be listed here.

Abstract

This review focuses on recent findings of the physiological and pharmacological role of non-endocannabinoid N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs) in the intestine and their involvement in the gut-brain signalling. Dietary fat suppresses food intake, and much research concerns the known gut peptides, for example, glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK). NAEs and 2-MAGs represent another class of local gut signals most probably involved in the regulation of food intake. We discuss the putative biosynthetic pathways and targets of NAEs in the intestine as well as their anorectic role and changes in intestinal levels depending on the dietary status. NAEs can activate the transcription factor PPARα, but studies to evaluate the role of endogenous NAEs are generally lacking. Finally, we review the role of diet-derived 2-MAGs in the secretion of anorectic gut peptides via activation of GPR119. Both PPARα and GPR119 have potential as pharmacological targets for the treatment of obesity and the former for treatment of intestinal inflammation. LINKED ARTICLES: This article is part of a themed section on 8 European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.

Citing Articles

The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats.

Lopez-Tofino Y, Hopkins M, Bagues A, Boullon L, Abalo R, Llorente-Berzal A Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458898 PMC: 11509924. DOI: 10.3390/ph17101256.

Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome.

Ellermann M Adv Drug Alcohol Res. 2024; 3:11359.

PMID: 38389811 PMC: 10880783. DOI: 10.3389/adar.2023.11359.

Direct effect of 2-palmitoyl glycerol on promotion of gamma aminobutyric acid synthesis in normal human fetal-derived astrocytes.

Tsuboi M, Nakamura Y, Sakuma H FEBS Open Bio. 2023; 13(7):1320-1332.

PMID: 37199045 PMC: 10315726. DOI: 10.1002/2211-5463.13649.

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.

Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett A, Hua T Pharmacol Rev. 2023; 75(5):885-958.

PMID: 37164640 PMC: 10441647. DOI: 10.1124/pharmrev.122.000600.

Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.

Chester L, Englund A, Chesney E, Oliver D, Wilson J, Sovi S Cannabis Cannabinoid Res. 2022; 9(1):188-198.

PMID: 36493386 PMC: 10874814. DOI: 10.1089/can.2022.0174.

References

Bashashati M, Storr M, Nikas S, Wood J, Godlewski G, Liu J . Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. Br J Pharmacol. 2011; 165(5):1556-71. PMC: 3372737. DOI: 10.1111/j.1476-5381.2011.01644.x. View

Feinle-Bisset C . Upper gastrointestinal sensitivity to meal-related signals in adult humans - relevance to appetite regulation and gut symptoms in health, obesity and functional dyspepsia. Physiol Behav. 2016; 162:69-82. DOI: 10.1016/j.physbeh.2016.03.021. View

Hodge D, Glass L, Diakogiannaki E, Pais R, Lenaghan C, Smith D . Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells. Peptides. 2015; 77:16-20. PMC: 4788502. DOI: 10.1016/j.peptides.2015.06.012. View

Alhouayek M, Bottemanne P, Subramanian K, Lambert D, Makriyannis A, Cani P . N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. FASEB J. 2014; 29(2):650-61. PMC: 4763939. DOI: 10.1096/fj.14-255208. View

Karwad M, Macpherson T, Wang B, Theophilidou E, Sarmad S, Barrett D . Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα. FASEB J. 2016; 31(2):469-481. DOI: 10.1096/fj.201500132. View

Husted A, Trauelsen M, Rudenko O, Hjorth S, Schwartz T . GPCR-Mediated Signaling of Metabolites. Cell Metab. 2017; 25(4):777-796. DOI: 10.1016/j.cmet.2017.03.008. View

Wei B, Mikkelsen T, McKinney M, Lander E, Cravatt B . A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem. 2006; 281(48):36569-78. DOI: 10.1074/jbc.M606646200. View

Alexander S, Cidlowski J, Kelly E, Marrion N, Peters J, Faccenda E . THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors. Br J Pharmacol. 2017; 174 Suppl 1:S208-S224. PMC: 5650662. DOI: 10.1111/bph.13880. View

Movahed P, Jonsson B, Birnir B, Wingstrand J, Jorgensen T, Ermund A . Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem. 2005; 280(46):38496-504. DOI: 10.1074/jbc.M507429200. View

10.

Igarashi M, DiPatrizio N, Narayanaswami V, Piomelli D . Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents. Biochim Biophys Acta. 2015; 1851(9):1218-26. PMC: 4516666. DOI: 10.1016/j.bbalip.2015.05.006. View

11.

Wang B, Rong X, Duerr M, Hermanson D, Hedde P, Wong J . Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. Cell Metab. 2016; 23(3):492-504. PMC: 4785086. DOI: 10.1016/j.cmet.2016.01.001. View

12.

Hassing H, Fares S, Larsen O, Pad H, Hauge M, Jones R . Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119. Biochem Pharmacol. 2016; 119:66-75. DOI: 10.1016/j.bcp.2016.08.018. View

13.

Proulx K, Cota D, Castaneda T, Tschop M, DAlessio D, Tso P . Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. Am J Physiol Regul Integr Comp Physiol. 2005; 289(3):R729-37. DOI: 10.1152/ajpregu.00029.2005. View

14.

Long J, LaCava M, Jin X, Cravatt B . An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J Lipid Res. 2010; 52(2):337-44. PMC: 3023554. DOI: 10.1194/jlr.M012153. View

15.

DiPatrizio N, Piomelli D . Intestinal lipid-derived signals that sense dietary fat. J Clin Invest. 2015; 125(3):891-8. PMC: 4362267. DOI: 10.1172/JCI76302. View

16.

Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G . Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther. 2004; 313(1):352-8. DOI: 10.1124/jpet.104.078980. View

17.

Young S, Zechner R . Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 2013; 27(5):459-84. PMC: 3605461. DOI: 10.1101/gad.209296.112. View

18.

Cvijanovic N, Isaacs N, Rayner C, Feinle-Bisset C, Young R, Little T . Duodenal fatty acid sensor and transporter expression following acute fat exposure in healthy lean humans. Clin Nutr. 2016; 36(2):564-569. DOI: 10.1016/j.clnu.2016.02.005. View

19.

Psichas A, Reimann F, Gribble F . Gut chemosensing mechanisms. J Clin Invest. 2015; 125(3):908-17. PMC: 4362249. DOI: 10.1172/JCI76309. View

20.

Kleberg K, Hassing H, Hansen H . Classical endocannabinoid-like compounds and their regulation by nutrients. Biofactors. 2014; 40(4):363-72. DOI: 10.1002/biof.1158. View